TGF-β supports the pro-tumor N2 polarization by promoting angiogenesis through VEGF secretion, enhancing metastatic potential, and suppressing immune activation by upregulating PD-L1 expression, ultimately establishing an immunosuppressive tumor niche [61]. This evidence concerns the gene TGFB1 and neoplasm.